Key result
Six to 8 years after acute deep-vein thrombosis, 42% of patients had died, primarily from preexisting cancer or cardiovascular disease, while recurrent venous thromboembolism occurred in 15%.
Population
124 patients with acute deep-vein thrombosis
Design
Cohort
Follow-up
6 to 8 years
Authors
Loading...
Supports integrated comorbidity management after DVT; leaves open optimal strategies to mitigate recurrence and symptoms.
Cohort (n=124)
Long-term follow-up of DVT patients reveals high mortality driven by preexisting cancer or cardiovascular disease, relatively low VTE recurrence, but frequent postphlebitic symptoms that negatively impact quality of life.
Rebecca J. Beyth (1995) conducted a cohort in acute deep-vein thrombosis (n=124). Acute deep-vein thrombosis was evaluated on Death. Six to 8 years after acute deep-vein thrombosis, 42% of patients had died, primarily from preexisting cancer or cardiovascular disease, while recurrent venous thromboembolism occurred in 15%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: